Prospective characterization of pathological features of Prostatic Carcinomas Detected Via Serum Prostate Specific Antigen Based Screening
- 1 March 1996
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- The Pathological Features and Prognosis of Prostate Cancer Detectable With Current Diagnostic TestsJournal of Urology, 1994
- The Nature of Prostate Cancer Detected Through Prostate Specific Antigen Based ScreeningJournal of Urology, 1994
- Radical Prostatectomy for Impalpable Prostate Cancer: The Johns Hopkins Experience With Tumors Found on Transurethral Resection (Stages T1a and T1b) and on Needle Biopsy (Stage T1c)Journal of Urology, 1994
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- PSA-DETECTED (CLINICAL STAGE T1c OR B0) PROSTATE CANCERUrologic Clinics of North America, 1993
- Clinical stage Bo or T1c prostate cancer: Nonpalpable disease identified by elevated serum prostate-specific antigen concentrationUrology, 1993
- Screening for Prostatic Carcinoma with Prostate Specific AntigenJournal of Urology, 1992
- Early detection of prostate cancerHuman Pathology, 1992
- Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the ProstateJournal of Urology, 1991
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991